BENGALURU: On 1 August 2023, the U.S. Court of Appeals ruled that the Antrix Corporation “enjoyed immunity under the Foreign Sovereign Immunities Act.” The ruling essentially reversed the confirmation provided in November 2020, by the District Court of Seattle, in exercising personal jurisdiction over Antrix when they had claimed immunity under the Foreign Sovereign Immunities […]Read More